|
Volumn 98, Issue 1, 2006, Pages 227-228
|
Just hold on a minute (or should it be two?)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
APOMORPHINE;
DAPOXETINE;
DOPAMINE 3 RECEPTOR BLOCKING AGENT;
DOPAMINE 4 RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
EMLA;
FLUOXETINE;
LIDOCAINE;
PARTIAL AGONIST;
PRILOCAINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
SILDENAFIL;
STEROID 5ALPHA REDUCTASE INHIBITOR;
ZIMELDINE;
BEHAVIOR MODIFICATION;
COMPARATIVE STUDY;
CONDOM;
DEPRESSION;
DRUG ABSORPTION;
DRUG DELIVERY SYSTEM;
EVIDENCE BASED MEDICINE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
MINIMALLY INVASIVE SURGERY;
NEUROMODULATION;
OFF LABEL DRUG USE;
PATIENT COMPLIANCE;
PHARMACODYNAMICS;
PRACTICE GUIDELINE;
PREMATURE EJACULATION;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
PSYCHOTHERAPY;
QUALITY OF LIFE;
REVIEW;
RISK BENEFIT ANALYSIS;
SCORING SYSTEM;
SEROTONINERGIC SYSTEM;
SEX THERAPY;
SEXUAL SATISFACTION;
STANDARD;
SYNCOPE;
TREATMENT INDICATION;
BENZYLAMINES;
DRUG APPROVAL;
EJACULATION;
HUMANS;
MALE;
NAPHTHALENES;
SEXUAL DYSFUNCTION, PHYSIOLOGICAL;
|
EID: 33745064323
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/j.1464-410X.2006.06356.x Document Type: Review |
Times cited : (1)
|
References (2)
|